Teva Pharma's most recent trend suggests a bearish bias. One trading opportunity on Teva Pharma is a Bear Call Spread using a strike $57.50 short call and a strike $62.50 long call offers a potential 16.82% return on risk over the next 32 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $57.50 by expiration. The full premium credit of $0.72 would be kept by the premium seller. The risk of $4.28 would be incurred if the stock rose above the $62.50 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Teva Pharma is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Teva Pharma is bearish.
The RSI indicator is at 37.16 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Teva Pharma
Pfizer Ponies Up to Develop Long-acting Growth Hormone
Tue, 16 Dec 2014 16:38:00 GMT
Teva's (TEVA) 2015 Guidance Hit By Generics
Fri, 12 Dec 2014 21:20:02 GMT
Street Talk: Interesting Costco call
Fri, 12 Dec 2014 19:43:00 GMT
Teva Upgraded On Strength Of Copaxone MS Drug
Fri, 12 Dec 2014 15:38:00 GMT
UPDATE: Sterne Agee Upgrades Teva Pharmaceutical
Fri, 12 Dec 2014 14:12:38 GMT
Also on Market Tamer…
Follow Us on Facebook